Ingrezza (valbenazine) comes hot on the heels of a rival drug from Teva, Austedo (deutetrabenazine) which gained FDA clearance for the treatment of chorea associated with Huntington’s disease ...

Competition to Austedo and Xenazine is also looming from Neurocrine Biosciences, whose VMAT2 drug Ingrezza (valbenazine) is already approved to treat tardive dyskinesia with a phase 3 readout in ...

Neurocrine (NBIX) Biosciences presented data from the KINECT-HD study showcasing significant improvements in chorea across body regions with once-daily INGREZZA capsules in adults with Huntington ...

Neurocrine Biosciences, Inc. (NASDAQ:NBIX)’s flagship product, INGREZZA, is used to treat tardive dyskinesia and chorea in Huntington’s disease. The company also offers CRENESSITY, a first-in ...

MANCHESTER UNITED are through to the Champions League quarter-finals after DOMINATING Real Sociedad at Old Trafford. Mikel Oyarzabal scored his second penalty of the tie in the first ten minutes ...

AUSTEDO to treat neurodegenerative and movement disorders – chorea associated with Huntington’s disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick ...

The company’s products include INGREZZA for tardive dyskinesia and chorea associated with Huntington’s disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital ...

Making the choice between buying a new Apple MacBook Air vs MacBook Pro buying decision is trickier than ever because while both are great laptops, they excel at different things and come in a ...

LAS VEGAS (KLAS) — Prescription medication costs are forcing some hard choices for many Nevadans. Two years ago, a proposal that offered hope sailed through the Democrat-majority Nevada Legislature ...

After hours: March 17 at 4:20:00 PM EDT Loading Chart for NBIX ...

Sports Mole provides in-depth previews and predictions for every match from the biggest leagues and competitions in world football.